Recently, Lilly announced that the US FDA approved the company's development of Reyvow (lasmidit
READ MORE 2019-10-20News List
FDA approves Lilly Reyvow
The third anti-tb drug was approved by the FDA
On August 14th, the FDA approved TB Alliance new fluorine-containing anti-tuberculosis drug Pretoman
READ MORE 2019-09-23
Holiday Notice of Mid-Autumn Festival
To all departments and all employees:According to the related provisions on national holidays &
READ MORE 2019-09-10
CPhI North America 2020 in Philadelphia USA Booth#1506
FluoroPharm will exhibit CPhI North America 2020 in Pennsylvania Convention Center,Philadelphia, PA,
READ MORE 2019-08-26
FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor
The U.S. Food and Drug Administration today granted accelerated approval to Rozlytrek (entrectinib),
READ MORE 2019-08-19
The 150 millionth chemical substance was born!
According to the American Chemical and Engineering News (C&EN), the American Chemical Abstracts
READ MORE 2019-08-07
FDA approves Novartis Piqray® - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer
Novartis today announced the US Food and Drug Administration (FDA) has approved Piqray® (alpelisib)
READ MORE 2019-07-11
New drug delivery method, FDA approved a new epilepsy treatment
UCB announced that the USFDA has approved Nayzilam (midazolam) nasal spray for the acute treatment o
READ MORE 2019-06-28
Holiday Notice of Dragon Boat Festival
To all departments and employees:According to the related national legal & the actual situation
READ MORE 2019-05-31
Long-term anti-AIDS, Combination of two schemes submits application
On April 29, 2019，the anti-AIDS long-acting two-party “cabotegravir + Ripirilin”submitted to the FDA
READ MORE 2019-05-28